This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svenungsson, B.
Right arrow Articles by Åkerlund, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svenungsson, B.
Right arrow Articles by Åkerlund, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2003, p. 4031-4037, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4031-4037.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Epidemiology and Molecular Characterization of Clostridium difficile Strains from Patients with Diarrhea: Low Disease Incidence and Evidence of Limited Cross-Infection in a Swedish Teaching Hospital

Bo Svenungsson,1,2* Lars G. Burman,3 Kirsti Jalakas-Pörnull,4 Åsa Lagergren,1 Johan Struwe,1,4 and Thomas Åkerlund3

Division of Infectious Diseases,1 Division of Clinical Bacteriology, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Huddinge,4 Department of Communicable Disease Control and Prevention, Karolinska Hospital,2 Department of Molecular Epidemiology and Biotechnology, Swedish Institute for Infectious Disease Control, Stockholm, Sweden3

Received 16 July 2002/ Returned for modification 2 December 2002/ Accepted 13 June 2003

We prospectively studied the epidemiology of Clostridium difficile-associated diarrhea (CDAD) in a 900-bed hospital over the course of 12 months by PCR-ribotyping of C. difficile isolates. A total of 304 cases were diagnosed, corresponding to an overall incidence of 7/1,000 admissions, with higher rates in nephrology, hematology, and organ transplantation wards (37, 30, and 21/1,000), and 72% were classified as hospital associated (onset in hospital or onset at home but after a hospital stay within 2 months). All 382 isolates from 227 of 304 (75%) patients available for PCR-ribotyping were typeable, yielding 70 PCR-ribotypes. The three most common types comprised 30% of hospital-associated and 34% of community-associated cases, indicating import via admitted patients as a major source of C. difficile strains occurring in the hospital. Of the 227 patients studied, 38% each contributed 2 to 13 fecal samples positive for C. difficile over the course of the study period. Repeat isolates of the same PCR-ribotype as the first isolate were found in 79% of these patients and in 95% of specimens delivered within 30 days, compared to 63% of those obtained at 31 to 204 days. Nosocomial acquisition of CDAD, defined as the proportion of cases sharing C. difficile type and admitted to the same ward within 2 or 12 months, was 20% and 32% of hospital-associated cases and 14% and 23% of all cases, respectively. Thus, most CDAD cases diagnosed over the course of the study period, including those associated with hospitalization, appeared to be caused by endogenous C. difficile strains rather than by strains truly being acquired in the hospital.

* Corresponding author. Mailing address: Department of Communicable Disease Control and Prevention, Karolinska Institute, Norrbacka, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Phone: 46 8 51773422. Fax: 46 8 315767. E-mail: bo.svenungsson{at}sme.sll.se.

Journal of Clinical Microbiology, September 2003, p. 4031-4037, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4031-4037.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Monaghan, T, Boswell, T, Mahida, Y R (2009). Recent advances in Clostridium difficile-associated disease. Postgrad. Med. J. 85: 152-162 [Abstract] [Full Text]  
  • Monaghan, T, Boswell, T, Mahida, Y R (2008). Recent advances in Clostridium difficile-associated disease. Gut 57: 850-860 [Abstract] [Full Text]  
  • Akerlund, T., Persson, I., Unemo, M., Noren, T., Svenungsson, B., Wullt, M., Burman, L. G. (2008). Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1. J. Clin. Microbiol. 46: 1530-1533 [Abstract] [Full Text]  
  • Sadeghifard, N., Gurtler, V., Beer, M., Seviour, R. J. (2006). The Mosaic Nature of Intergenic 16S-23S rRNA Spacer Regions Suggests rRNA Operon Copy Number Variation in Clostridium difficile Strains. Appl. Environ. Microbiol. 72: 7311-7323 [Abstract] [Full Text]  
  • Aspevall, O., Lundberg, A., Burman, L. G., Akerlund, T., Svenungsson, B. (2006). Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital.. Antimicrob. Agents Chemother. 50: 1890-1892 [Abstract] [Full Text]  
  • Akerlund, T., Svenungsson, B., Lagergren, A., Burman, L. G. (2006). Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates. J. Clin. Microbiol. 44: 353-358 [Abstract] [Full Text]  
  • Arroyo, L. G, Kruth, S. A, Willey, B. M, Staempfli, H. R, Low, D. E, Weese, J S. (2005). PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol 54: 163-166 [Abstract] [Full Text]  
  • Schaier, M., Wendt, C., Zeier, M., Ritz, E. (2004). Clostridium difficile diarrhoea in the immunosuppressed patient--update on prevention and management. Nephrol Dial Transplant 19: 2432-2436 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»